Yubo International Biotech Limited
Yubo International Biotech Limited, through its subsidiaries, focuses on the research, development, and application of endometrial stem cells. The company offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting ser… Read more
Yubo International Biotech Limited (YBGJ) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.224x
Based on the latest financial reports, Yubo International Biotech Limited (YBGJ) has a cash flow conversion efficiency ratio of 0.224x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-359.06K) by net assets ($-1.60 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Yubo International Biotech Limited - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how Yubo International Biotech Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Yubo International Biotech Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Yubo International Biotech Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Baiya International Group Inc. Ordinary Shares
NASDAQ:BIYA
|
N/A |
|
Osteopore Ltd
AU:OSX
|
3.011x |
|
Signet International Holdings Inc
PINK:AQPW
|
-0.732x |
|
Core Assets Corp
OTCQB:CCOOF
|
-0.031x |
|
2U, Inc.
PINK:TWOUQ
|
0.333x |
|
Kedaung Indah Can Tbk
JK:KICI
|
-0.009x |
|
Public Service Company of New Mexico PFD 4.58%
PINK:PNMXO
|
-0.016x |
|
Anagenics Ltd
AU:AN1
|
-0.286x |
Annual Cash Flow Conversion Efficiency for Yubo International Biotech Limited (2002–2024)
The table below shows the annual cash flow conversion efficiency of Yubo International Biotech Limited from 2002 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-3.30 Million | $-1.34 Million | 0.406x | +1.21% |
| 2023-12-31 | $-1.84 Million | $-738.97K | 0.401x | +432.11% |
| 2022-12-31 | $-565.37K | $68.23K | -0.121x | -101.55% |
| 2021-12-31 | $-131.20K | $-1.02 Million | 7.781x | +8885.85% |
| 2020-12-31 | $1.17 Million | $101.11K | 0.087x | -77.18% |
| 2019-12-31 | $-1.80 Million | $-682.12K | 0.379x | +1872.76% |
| 2018-12-31 | $-1.66 Million | $-32.00K | 0.019x | -46.99% |
| 2017-12-31 | $-1.52 Million | $-55.00K | 0.036x | -9.50% |
| 2016-12-31 | $-1.37 Million | $-55.00K | 0.040x | -9.95% |
| 2015-12-31 | $-1.26 Million | $-56.00K | 0.045x | -13.23% |
| 2014-12-31 | $-1.23 Million | $-63.00K | 0.051x | +22.90% |
| 2013-12-31 | $-1.10 Million | $-46.00K | 0.042x | -0.48% |
| 2012-12-31 | $-906.00K | $-38.00K | 0.042x | -21.67% |
| 2011-12-31 | $-803.00K | $-43.00K | 0.054x | -21.42% |
| 2010-12-31 | $-719.00K | $-49.00K | 0.068x | -7.77% |
| 2009-12-31 | $-609.00K | $-45.00K | 0.074x | -14.12% |
| 2008-12-31 | $-523.00K | $-45.00K | 0.086x | -22.36% |
| 2007-12-31 | $-388.00K | $-43.00K | 0.111x | -37.94% |
| 2006-12-31 | $-308.00K | $-55.00K | 0.179x | -73.15% |
| 2005-12-31 | $-194.00K | $-129.00K | 0.665x | -2.50% |
| 2004-12-31 | $-283.00K | $-193.00K | 0.682x | -75.08% |
| 2003-12-31 | $-182.00K | $-498.00K | 2.736x | +100.72% |
| 2002-12-31 | $6.00K | $-2.27 Million | -378.000x | -- |